Novo Nordisk A/S - Welcome to our Media section


	FDA Approves NOVO NORDISK's NovoSeven® RT (Coagulation Factor VIIa [Recombinant] Room Temperature Stable) for Hemophilia Patients with Inhibitors Novo Nordisk today announced that the US Food and Drug Administration (FDA) has approved NovoSeven® RT (Coagulation Factor VIIa [Recombinant] Room Temperature ...

	Read more


	Leading Advocacy Groups Set National Diabetes Goal. The National Changing Diabetes® Program (NCDP), an initiative created by Novo Nordisk to improve the lives of people with diabetes, joined together with other a...

	Read more

Media contacts

Our Media Relations team is ready to help you get all the information you need about Novo Nordisk.

Subscribe to our e-mail notification service for news, publications and presentations

Lars Rebien Soerensen, CEO, comments on the full year results. Watch the interviews from CNBC Europe.